Pilot Text Message for Influenza Vaccination

Not Applicable

Completed

• Conditions: Influenza
• Interventions: Behavioral: text message

• Registration Number: NCT01761734
• Lead Sponsor: Columbia University

Brief Summary

Influenza is an important and potentially preventable cause of morbidity and mortality, yet only 46% of U.S. adults were vaccinated by the end of the 2011-12 influenza season despite influenza vaccination being widely recommended, effective, and safe. Influenza vaccination rates are even lower in racial/ethnic minority groups. In order to address the problem of low influenza vaccination rates in minority adults, we plan to build on the well-accepted practice of immunization recall-reminders and the emerging practice of using text message to pilot the feasibility of using text messaging to improve influenza vaccination coverage rates in a low health literacy, largely minority, publicly insured adult population.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2012-12-30
• Study Start: 2013-01
• Study First Submitted QC: 2013-01-04
• Study First Posted: 2013-01-07
• Primary Completion: 2013-03
• Study Completion: 2013-05
• Status Verified: 2014-06
• Last Update Submitted: 2014-06-22
• Last Update Posted: 2014-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• > or = 18 years of age,
• at least one visit to the AIM clinic during the previous year
• a cell phone number in the registration system
• fluent in English or Spanish. Exclusion criteria

Read More

Exclusion Criteria

• Receipt of influenza vaccination during the 2012-2013 influenza season prior to randomization.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
text message	text message	receipt of text message

Primary Outcome Measures

Name	Time	Method
Receipt of an influenza vaccine dose	March 31, 2013	Proportion of individuals in each group receiving an influenza dose by the end of the influenza season

Trial Locations

Locations (1)

Columbia University; 🇺🇸 New York, New York, United States